Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pathol Int ; 72(5): 273-282, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35234319

RESUMEN

Bronchiolar adenoma (BA) is a rare benign lung tumor that shows proliferation of bland bronchiolar-type epithelium containing a continuous layer of basal cells. This tumor entity has been newly added to the recent World Health Organization (WHO) classification 5th edition. This entity encompasses a spectrum of lesions: the classic ciliated muconodular papillary tumor (CMPT) and the non-classic CMPT. Although BA is reported to have driver mutations including BRAF V600E, EGFR, and KRAS, the molecular profile of BA is still incompletely understood. Five resected BAs at our institutions were analyzed. The BA lesions were subdivided into two groups: three proximal-type BAs and two distal-type BAs. NRAS codon 12/13 mutation and EML4 exon 20-ALK exon 20 fusion were found in two of the three proximal-types. BRAF V600E mutation was found in one of the two distal-types. Two cases coexisted with lung adenocarcinoma, with EGFR exon 19 deletion and KRAS mutation, respectively. No recurrence was observed at a median of 12 months (range 2-84 months) of follow-up. BA has uncommon variants of mutation seen in lung adenocarcinoma. NRAS mutation and ALK fusion partner has not been reported previously. The present cases may reinforce the distinctive biology of BA from lung adenocarcinoma.


Asunto(s)
Adenocarcinoma del Pulmón , Adenoma , Neoplasias Pulmonares , Adenoma/genética , Adenoma/patología , Receptores ErbB/genética , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Mutación , Proteínas Proto-Oncogénicas B-raf/genética , Proteínas Proto-Oncogénicas p21(ras)/genética , Proteínas Tirosina Quinasas Receptoras/genética
2.
World J Surg ; 42(12): 4090-4096, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29922875

RESUMEN

BACKGROUND: To prevent leakage of pancreatic juice from the main pancreatic duct (MPD), complete external drainage appears to be the most effective technique. However, because this requires a pancreatic stent tube to be ligated with MPD, duct-to-mucosa pancreaticojejunostomy (PJ) is difficult. From our histopathological examination, a large amount of pancreatic juice is drained from the ducts other than MPD. This study aimed to evaluate our new conceptual technique of PJ after pancreaticoduodenectomy (PD). METHODS: We considered it important to drain pancreatic juice from the branch pancreatic ducts to the intestinal tract and to perform duct-to-mucosa PJ, while pancreatic juice from MPD is completely drained out of the body. We designed a technique that could simultaneously achieve these points. In our technique, which is based on conventional "two-row" anastomosis, a stent tube is fixed with MPD and its surrounding tissue by purse-string suture at the cut surface of the pancreas, and duct-to-mucosa PJ is concomitantly performed. RESULTS: Of 45 patients undergoing PD, 12 of soft pancreas underwent surgery with this technique. According to the classification of the International Study Group on Pancreatic Fistula, a Grade A PF was observed in four patients, whereas no patient had a Grade B or C PF. CONCLUSIONS: We propose our anastomotic technique that could simultaneously prevent PF and keep the pancreatic duct patent.


Asunto(s)
Pancreatoyeyunostomía/métodos , Adulto , Anciano , Anciano de 80 o más Años , Drenaje , Femenino , Humanos , Masculino , Persona de Mediana Edad , Conductos Pancreáticos/cirugía , Fístula Pancreática/prevención & control , Jugo Pancreático , Pancreatoyeyunostomía/efectos adversos , Stents
3.
Pathol Int ; 65(9): 468-75, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26126783

RESUMEN

The aims of this study were: (i) to elucidate clinicopathological characteristics of pcCHS of long bones (L), limb girdles (LG) and trunk (T) in Japan; (ii) to investigate predictive pathological findings for outcome of pcCHS of L, LG and T, objectively; and (iii) to elucidate a discrepancy of grade between biopsy and resected specimens. Clinicopathological profiles of 174 pcCHS (79 male, 95 female), of L, LG, and T were retrieved. For each case, a numerical score was given to 18 pathological findings. The average age was 50.5 years (15-80 years). Frequently involved sites were femur, humerus, pelvis and rib. The 5-year and 10-year disease-specific survival (DSS) rates [follow-up: 1-258 months (average 65.5)] were 87.0% and 80.4%, respectively. By Cox hazards analysis on pathological findings, age, sex and location, histologically higher grade and older age were unfavorable predictors, and calcification was a favorable predictor in DSS. The histological grade of resected specimen was higher than that of biopsy in 37.7% (26/69 cases). In conclusion, higher histological grade and older age were predictors for poor, but calcification was for good prognosis. Because there was a discrepancy in grade between biopsy and resected specimens, comprehensive evaluation is necessary before definitive operation for pcCHS.


Asunto(s)
Neoplasias Óseas/patología , Condrosarcoma/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Fémur/patología , Técnicas Histológicas , Humanos , Húmero/patología , Japón , Masculino , Persona de Mediana Edad , Pronóstico , Tasa de Supervivencia , Adulto Joven
4.
Gynecol Oncol ; 120(2): 239-46, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21130491

RESUMEN

OBJECTIVE: Although histological and epidemiological studies have suggested that endometriosis has malignant potential, the molecular mechanism underlying the malignant transformation of endometriosis is poorly understood. Ovarian cancer arising from endometriosis (OCEM) may provide an ideal model for genetic studies. To investigate the genetic alterations during transformation of ovarian endometriosis into cancer, we analysed loss of heterozygosity (LOH) and mutations of tumour-related genes in OCEM cases (n=12) that fulfilled the histological criteria and in solitary ovarian endometriosis (n=12). METHODS: Each paraffin-embedded section was microdissected to isolate the endometriotic epithelium, transitional epithelium, and cancer cells. Extracted DNA was amplified by nested PCR. LOH was identified with fluorescence-labelled microsatellite markers. Mutations of tumour-related genes PTEN, TP53, and K-ras were examined by bidirectional DNA sequencing. RESULTS: With 13 microsatellite markers on six chromosomes, we detected 31 and eight LOH events in OCEMs and in solitary ovarian endometriosis, respectively. In the OCEM group, 18 LOH events were found in cancer cells alone, while 13 LOH events were found in all cancer, transitional, and endometriotic tissues. High frequencies of LOH were detected on chromosomes 9p, 10q, and 13q. However, only two point mutations were detected in cancer cells in one case. CONCLUSION: Our study suggested that accumulated LOH events on some chromosome loci may be involved in malignant transformation of endometriosis, while mutations in certain tumour-related genes are not.


Asunto(s)
Transformación Celular Neoplásica/genética , Endometriosis/genética , Pérdida de Heterocigocidad , Neoplasias Ováricas/genética , Adenocarcinoma de Células Claras/genética , Adenocarcinoma de Células Claras/patología , Adulto , Carcinoma Endometrioide/genética , Carcinoma Endometrioide/patología , Transformación Celular Neoplásica/patología , Endometriosis/patología , Femenino , Genes Supresores de Tumor , Genes p53 , Genes ras , Humanos , Repeticiones de Microsatélite , Persona de Mediana Edad , Mutación , Neoplasias Ováricas/patología , Fosfohidrolasa PTEN/genética , Adhesión en Parafina , Adulto Joven
5.
J Obstet Gynaecol Res ; 37(12): 1842-6, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21827573

RESUMEN

We present a rare case of alpha-fetoprotein (AFP) producing ovarian clear cell carcinoma. This is the first report of a clear cell ovarian carcinoma with hepatoid carcinoma arising from endometriosis. A 54-year-old menopausal woman had a primary ovarian carcinoma of International Federation of Gynecology and Obstetrics stage IIIc. Serum level of AFP was 4195 ng/mL. Histological examination revealed clear cell adenocarcinoma arising from endometriosis with hepatoid carcinoma. Metastatic liver and lymph node tumors were found after 25 months from the first surgery. However, the patient's serum AFP was within normal limits. The recurrent and metastatic tumors disappeared in response to combined liposomal doxorubicin and carboplatin chemotherapy. She has had a disease-free survival of 4 years. In conclusion, the patient had a clear cell ovarian carcinoma with hepatoid carcinoma arising clearly from endometriosis. The recurrent tumors did not show a component of hepatoid carcinoma. Therefore, it is possible to expect better survival with good sensitivity to chemotherapy.


Asunto(s)
Adenocarcinoma de Células Claras/metabolismo , Carcinoma Endometrioide/patología , Carcinoma Hepatocelular/patología , Endometriosis/patología , Neoplasias Primarias Múltiples/patología , Neoplasias Ováricas/metabolismo , alfa-Fetoproteínas/metabolismo , Adenocarcinoma de Células Claras/patología , Adenocarcinoma de Células Claras/cirugía , Carcinoma Endometrioide/cirugía , Carcinoma Hepatocelular/cirugía , Endometriosis/cirugía , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Primarias Múltiples/cirugía , Neoplasias Ováricas/patología , Neoplasias Ováricas/cirugía
6.
J Obstet Gynaecol Res ; 37(12): 1860-3, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21955049

RESUMEN

Glassy cell carcinoma of the uterine cervix (GCC) is a rare form of cervical carcinoma that is characterized by aggressiveness and poor prognosis. We reviewed a variety of clinicopathological features, treatment strategies, and outcomes in three women with GCC. The three patients were successfully treated by radical hysterectomy with pelvic/para-aortic lymphadenectomy. The patients had stage Ib1, stage IIa, and stage Ib2 tumors without lymph node metastases. A 44-year-old woman with stage Ib1 tumor did not undergo adjuvant chemotherapy or radiation therapy. She had recurrent pelvic tumors 12 months after surgery, and died 6 months after the recurrent disease. The histological findings of her cervix, which were different from the other two patients, did not show the marked infiltration of eosinophils. The other two patients with stage Ib2 and IIa tumors underwent adjuvant chemotherapy with paclitaxel and carboplatin, and had disease-free survival for 4.5 and 9 years. We think that all patients with GCC of stage Ib1 or more should undergo adjuvant chemotherapy of paclitaxel and carboplatin or other adjuvant therapies.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Neoplasias del Cuello Uterino/tratamiento farmacológico , Adulto , Carboplatino/administración & dosificación , Carboplatino/uso terapéutico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/cirugía , Cuello del Útero/patología , Cuello del Útero/cirugía , Supervivencia sin Enfermedad , Femenino , Humanos , Paclitaxel/administración & dosificación , Paclitaxel/uso terapéutico , Resultado del Tratamiento , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/cirugía
7.
Respirol Case Rep ; 8(7): e00625, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32695401

RESUMEN

Advanced granulocyte colony-stimulating factor (G-CSF)-producing lung tumours are generally refractory to platinum-based chemotherapy and are associated with poor prognosis. However, therapeutic strategies for these tumours remain unknown. A 74-year-old man was diagnosed with non-small cell lung cancer-not otherwise specified (NSCLC-NOS); the clinical stage was T4N0M1c stage IVb. Blood testing showed leucocytosis and aberrant G-CSF expression. We chose single-agent pembrolizumab as the initial treatment because PD-L1 was highly expressed in the tumours. A clinically favourable response was achieved from seven courses of pembrolizumab with a total disease-free survival of 10 months. During this period, the blood leucocyte count was concordant with the disease condition. These observations showed that pembrolizumab monotherapy may be an effective treatment for patients with advanced G-CSF-producing NSCLC-NOS and that the monitoring of leucocyte count may be a useful biomarker for predicting the efficacy of pembrolizumab monotherapy.

8.
Nat Commun ; 8(1): 2238, 2017 12 21.
Artículo en Inglés | MEDLINE | ID: mdl-29269828

RESUMEN

Liver metabolism undergoes robust circadian oscillations in gene expression and enzymatic activity essential for liver homeostasis, but whether the circadian clock controls homeostatic self-renewal of hepatocytes is unknown. Here we show that hepatocyte polyploidization is markedly accelerated around the central vein, the site of permanent cell self-renewal, in mice deficient in circadian Period genes. In these mice, a massive accumulation of hyperpolyploid mononuclear and binuclear hepatocytes occurs due to impaired mitogen-activated protein kinase phosphatase 1 (Mkp1)-mediated circadian modulation of the extracellular signal-regulated kinase (Erk1/2) activity. Time-lapse imaging of hepatocytes suggests that the reduced activity of Erk1/2 in the midbody during cytokinesis results in abscission failure, leading to polyploidization. Manipulation of Mkp1 phosphatase activity is sufficient to change the ploidy level of hepatocytes. These data provide clear evidence that the Period genes not only orchestrate dynamic changes in metabolic activity, but also regulate homeostatic self-renewal of hepatocytes through Mkp1-Erk1/2 signaling pathway.


Asunto(s)
Fosfatasa 1 de Especificidad Dual/metabolismo , Hepatocitos/metabolismo , Hígado/metabolismo , Sistema de Señalización de MAP Quinasas/fisiología , Proteínas Circadianas Period/genética , Poliploidía , Animales , Relojes Circadianos/genética , Hepatocitos/citología , Hepatocitos/patología , Hígado/citología , Hígado/patología , Ratones , Ratones Noqueados , Microscopía , Imagen de Lapso de Tiempo
9.
Urology ; 86(3): 565-9, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26199172

RESUMEN

OBJECTIVE: To investigate factors predicting that combination therapy would be insufficient in terms of efficacy, necessitating conversion to surgical intervention, in patients with lower urinary tract symptoms and/or benign prostatic enlargement. MATERIALS AND METHODS: In total, 218 patients given combination therapy for 6 months or more were enrolled in our study. Candidate factors for surgical intervention before dutasteride administration were statistically analyzed. We also examined the proportion of stromal components in resected specimens of the intravesical prostatic protrusion (IPP) portion using the point-counting technique according to IPP grades. RESULTS: Combination therapy was effective and was thus continued in 172 patients, whereas 46 required surgical intervention. The comparison between these two groups, by multivariate analysis, revealed significant differences in IPP and total International Prostate Symptom Score (IPSS). IPP (odds ratio 1.133, P <.001) was the strongest independent factor predicting conversion to surgical intervention. Receiver operating characteristic analysis identified the optimal cutoff value of IPP to be 8 mm (area under the curve: 0.9). This value yielded a sensitivity of 91% and a specificity of 72%. In addition, the mean proportion of stromal components in resected specimens of IPP according to IPP grades was grade I: 96.7%, grade II: 57.8%, and grade III: 21.4% (P <.001 for all), respectively. CONCLUSION: Our results suggest that in lower urinary tract symptoms and/or benign prostatic enlargement associated with severe IPP, combination therapy might have insufficient efficacy due to a low proportion of stromal components, necessitating conversion to surgical intervention.


Asunto(s)
Resistencia a Medicamentos , Dutasterida/farmacología , Terapia por Láser , Próstata/diagnóstico por imagen , Hiperplasia Prostática/complicaciones , Obstrucción del Cuello de la Vejiga Urinaria/tratamiento farmacológico , Vejiga Urinaria/diagnóstico por imagen , Inhibidores de 5-alfa-Reductasa/farmacología , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Tamaño de los Órganos , Próstata/patología , Próstata/cirugía , Hiperplasia Prostática/diagnóstico , Hiperplasia Prostática/cirugía , Curva ROC , Estudios Retrospectivos , Ultrasonografía , Obstrucción del Cuello de la Vejiga Urinaria/etiología , Obstrucción del Cuello de la Vejiga Urinaria/fisiopatología , Urodinámica
10.
Surg Case Rep ; 1(1): 104, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26943428

RESUMEN

We aimed to histologically observe portal venous gas (PVG)-causing intestinal pneumatosis (IP) and evaluate pathogenic mechanisms and therapeutic strategies, including decisions on whether emergency surgery should be performed. Autopsy was performed in two cases of nonocclusive mesenteric ischemia (NOMI). We directly histologically observed the pathogenic mechanisms of IP caused by gas-producing bacteria and IP considered to be caused by mechanical damage to the intestinal mucosa. IP can be classified hypothetically into the following types according to pathogenesis: (1) infection, (2) rupture (damage) of the intestinal mucosa + increased intestinal intraluminal pressure, and (3) mixed type. In cases of IP caused by gas-producing bacteria or IP associated with intestinal wall damage extending beyond the mucosa to the deep muscular layer, emergency surgery should be considered. However, it is highly possible that patients who test negative for infection with gas-producing bacteria whose intestinal wall damage remains only in the mucosa can be conservatively treated.

11.
Korean J Urol ; 54(4): 271-3, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23614067

RESUMEN

A 66-year-old man with a history of multiple transurethral resections for recurrent bladder tumors, staged as Ta according to the International Union Against Cancer staging guidelines, presented with a complaint of dry cough. A round nodule with a diameter of 7.5 cm was detected in the lung by chest computed tomography, and a video-assisted thoracoscopic lobectomy was performed. Pulmonary metastasis of recurrent bladder cancer was diagnosed by immunohistochemistry staining for the urothelium-specific protein uroplakin Ia. Subsequently, 2 cycles of systemic chemotherapy were administered. Two and a half years after treatment, no recurrence of pulmonary lesions has been detected. A combination of complete resection of pulmonary lesions and systemic chemotherapy may result in a good prognosis for patients with non-muscle-invasive bladder cancer.

12.
In Vitro Cell Dev Biol Anim ; 47(10): 707-15, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21975854

RESUMEN

The proliferation and differentiation of the small intestinal epithelium depends on the microenvironment surrounding the stem cells, such as intestinal subepithelial myofibroblasts. Although there have been many culture studies of intestinal epithelial­mesenchymal interaction, a culture which allows long-term observations has been difficult. This study investigated the influence of intestinal subepithelial myofibroblasts on the proliferation and differentiation of intestinal epithelial cells with a relatively long-term observation of 3 wk using a 3D co-culture system. Cultured rat intestinal subepithelial myofibroblasts, obtained from the duodenum, were embedded in collagen gel and cells from the rat intestinal epithelial cell line IEC-6 seeded onto it. Histologic sections of the cell-embedded gels were made and histochemical and immunohistochemical examinations were carried out in conjunction with expression analysis of the pancreatic duodenal homeobox 1 (pdx-1) transcription factor in IEC-6 cells. The IEC-6 cells showed increased proliferation and displayed characteristic endocrine features when co-cultured with rat intestinal subepithelial myofibroblasts, arranging themselves into multilayer structures and becoming cuboidal, with abundant cytoplasm and oval nuclei. Some IEC-6 cells were immunohistochemically positive for chromogranin A and glicentin. They also expressed the pdx-1 transcription factor at both the mRNA and protein levels. The number and percentage of chromogranin A-positive cells increased with culture time, whereas no increase was observed in cells cultured without rat intestinal subepithelial myofibroblasts. The present study using a long-term 3D co-culture model has obtained evidence of the participation of intestinal subepithelial myofibroblasts in enteroendocrine differentiation, supported by the expression of pdx-1 and glicentin production.


Asunto(s)
Diferenciación Celular , Técnicas de Cocultivo/métodos , Sistema Endocrino/citología , Enterocitos/citología , Intestinos/citología , Miofibroblastos/citología , Animales , Factor de Transcripción CDX2 , Línea Celular , Enterocitos/metabolismo , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Inmunohistoquímica , Miofibroblastos/metabolismo , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transactivadores/genética , Transactivadores/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
13.
J Histochem Cytochem ; 59(8): 791-8, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21551319

RESUMEN

To ensure the maintenance of tissues in mammals, cell loss must be balanced with cell production, the proliferative activity being different from tissue to tissue. In this article, the authors propose a new method for the quantification of the proliferative activity, defined as the S-phase fraction of actively cycling cells, by dual labeling with fluorescence and peroxidase immunohistochemistry using BrdU (marker of S-phase) and Ki67 antibodies (marker of G(1)-, S-, G(2)-, and M-phases) after a one-step antigen retrieval. In the generative cell zones of fundic and pyloric glandular stomachs, where the majority of cells were cycling, the authors measured a proliferative activity of 31%. In the epithelium of the forestomach and the skin, where cycling cells are intermingled with G(0) and differentiated cells, proliferative activities were 21% and 13%, respectively. In the adrenal cortex, in which cycling cells were sparsely distributed, the proliferative activity reached 32%. During the regenerative process in the skin after a lesion, the proliferative activity increased in proximity to the wound. The present one-step dual-labeling method has revealed that the proliferative activity is different between tissues and depends on the physiological or pathological state.


Asunto(s)
Bromodesoxiuridina , Proliferación Celular , Antígeno Ki-67/metabolismo , Fase S , Glándulas Suprarrenales/citología , Glándulas Suprarrenales/metabolismo , Animales , Anticuerpos , Mucosa Gástrica/citología , Mucosa Gástrica/metabolismo , Inmunohistoquímica , Indicadores y Reactivos , Masculino , Ratones , Ratones Endogámicos C57BL , Piel/citología , Piel/lesiones , Piel/metabolismo , Coloración y Etiquetado , Estómago/citología , Cicatrización de Heridas
14.
Pancreas ; 38(2): e60-7, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19248224

RESUMEN

OBJECTIVE: With the aim of improving early detection of pancreatic carcinoma, we attempted to make correlations among positive immunohistochemical detection of p53 expression, mutations in the p53 gene, and detailed histologic features of pancreatic carcinoma. METHODS: Seven cases of invasive pancreatic ductal carcinoma demonstrating p53 overexpression were analyzed. Serial 4- and 20-microm sections from paraffin blocks were used for immunodetection of p53 protein and microdissection, respectively. We used direct sequencing of polymerase chain reaction at 101 p53-positive and 10 p53-negative sites to sequence exons 5 to 8 of p53 and then analyzed these results in concert with detailed histologic features. RESULTS: Regardless of the degree of p53 overexpression, we detected p53 point mutations in all p53-positive lesions, including 22 noninvasive sites, 17 invasive areas, and 1 lymph node metastasis. No significant correlations were measured between specific p53 mutations and histologic features. Within individual tumors, the same p53 mutation was generally, but not always, detected in different areas in invasive and noninvasive lesions. CONCLUSIONS: Our results demonstrate that p53 mutation is an early genetic event affecting a diversity of molecular pathways in pancreatic carcinogenesis and indicates a possibility of early diagnosis of pancreatic carcinoma by detecting a few p53-positive cells obtained from the pancreatic fluid.


Asunto(s)
Carcinoma Ductal Pancreático/genética , Genes p53 , Neoplasias Pancreáticas/genética , Mutación Puntual , Adulto , Anciano , Carcinoma Ductal Pancreático/patología , Femenino , Humanos , Antígeno Ki-67/análisis , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/patología , Proteína p53 Supresora de Tumor/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA